Conservative treatment of meibomian gland dysfunction

Eye and Contact Lens

Volumn 30, Issue 1, 2004, Pages 14-19

  Romero, Juan M ^a   Biser, Seth A ^b   Perry, Henry D ^a,b   Levinson, David H ^b   Doshi, Sima J ^b   Terraciano, Anthony ^a   Donnenfeld, Eric D ^b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

Author keywords

Blepharitis; Conservative therapy; Lid soaks; Meibomian gland dysfunction

Indexed keywords

ARTIFICIAL TEAR; PRESERVATIVE; SODIUM CHLORIDE; EYE DROPS;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; EYE BURNING; EYE IRRITATION; EYE PAIN; EYE PHOTOGRAPHY; EYELID; EYELID ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HYGIENE; INTRAOCULAR FOREIGN BODY; LACRIMATION; MALE; MEASUREMENT; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; OCULAR PRURITUS; PATIENT SELECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEBACEOUS GLAND DISEASE; SLIT LAMP; SYMPTOMATOLOGY; TELANGIECTASIA; THICKNESS; VISION; DRUG EFFECT; EYELID DISEASE; LACRIMAL FLUID; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; SECRETION;

ADULT; AGED; AGED, 80 AND OVER; EYELID DISEASES; FEMALE; HUMANS; HYGIENE; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SODIUM CHLORIDE; TEARS;

EID: 1842538037     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ICL.0000095229.01957.89     Document Type: Article

References (32)

1. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113:1266-1270.
2. Gilbard JP. Dry eye, blepharitis and chronic eye irritation: Divide and conquer. J Ophthalmic Nurs Technol 1999;18:109-115.
3. Smith RE, Flowers CW. Chronic blepharitis: A review. CLAO J 1995;21:200-207.
4. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996;40:343-367.
5. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease: Classification and grading of lid changes. Eye 1991;5:395-411.
6. Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea 1991;10:277-285.
7. McCulley JP. Blepharoconjunctivitis. Int Ophthalmol Clin 1984;24(2):65-77.
8. Dougherty JM, McCulley JP, Silvany RE, et al. The role of tetracycline in chronic blepharitis: Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991;32:2970-2975.
9. Stevenson OD, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose ranging, randomized trial. The Cyclosporine A Phase 2 Study Group. Ophthalmology 2000;107:967-974.
10. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporin A ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-639.
11. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980;87:218-221.
12. Paugh JR, Knapp LL, Martinson JR, et al. Meibomian therapy in problematic contact lens wear. Optom Vis Sci 1990;67:803-806.
13. Olson MC, Korb DR, Grainer JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003;29(2):96-99.
14. Goto E, Koji E, Suzuki A, et al. Improvement of tear stability following warm compression in patients with meibomian gland dysfunction. Adv Exp Med Biol 2002;506(pt B):1149-1152.
15. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-1180.
16. Shimazaki J, Goto E, Ono M, et al. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology 1998;105:1485-1488.
17. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998;116:849-852.
18. Shine WE, McCulley JP. Meibomian gland triglyceride fatty acid differences in chronic blepharitis patients. Cornea 1996;15:340-346.
19. Borrie P. Rosacea with special reference to its ocular manifestations and dry eyes. Br J Dermatol 1963;65:458-463.
20. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 1993;100:347-351.
21. Norn MS. Meibomian orifices and Marx's line studied by triple vital staining. Acta Ophthalmol 1985;63:698-700.
22. Hykin PG, Bron AJ. Age related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992;11:334-342.
23. Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995;14:144-145.
24. McCulley JP, Shine WE. Meibomian secretions in chronic blepharitis. Adv Exp Med Biol 1998;438:319-328.
25. Shine WE, Silvany R, McCulley JP. Relation of cholesterol-stimulated staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci 1993;34:2291-2296.
26. Key JE. A Comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996;22:209-212.
27. Wittpenn JR. EyeScrub: Simplifying the management of blepharitis. J Ophthalmic Nurs Technol 1995;14:25-28.
28. Staats P, Hekmat H, Staats A. Suggestion/placebo effects on pain: Negative as well as positive. J Pain Symptom Manage 1998;15(4):235-243.
29. Goto E, Monden Y, Takano Y, et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol 2002;86:1403-1407.
30. Jones EM, Bowker KE, Cooke R, et al. Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect 1997;35(1):59-62.
31. Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea 1991;10(1):50-53.
32. Heiligenhaus A, Koch JM, Kemper D, et al. Therapy of dry eye disorders. Klin Monatsbl Augenheilkd 1994;204:162-168.